Astrana Health (NASDAQ:ASTH) Hits New 52-Week Low After Earnings Miss

Astrana Health, Inc. (NASDAQ:ASTH)’s share price hit a new 52-week low during trading on Friday after the company announced weaker than expected quarterly earnings. The stock traded as low as $25.59 and last traded at $25.73, with a volume of 62907 shares traded. The stock had previously closed at $34.68.

The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). The business had revenue of $665.21 million during the quarter, compared to analysts’ expectations of $617.24 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Robert W. Baird boosted their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Macquarie raised Astrana Health to a “hold” rating in a research note on Monday, December 16th. Truist Financial dropped their price objective on Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research note on Monday, January 13th. Finally, Stifel Nicolaus decreased their target price on Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $65.60.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Louisiana State Employees Retirement System purchased a new position in Astrana Health during the third quarter worth $1,165,000. State of Alaska Department of Revenue acquired a new stake in shares of Astrana Health during the third quarter valued at $1,373,000. Nisa Investment Advisors LLC purchased a new stake in Astrana Health during the 3rd quarter worth about $35,000. New York State Teachers Retirement System purchased a new stake in Astrana Health during the 3rd quarter worth about $2,515,000. Finally, F M Investments LLC acquired a new position in Astrana Health in the 3rd quarter valued at about $11,738,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Stock Performance

The company has a market capitalization of $1.41 billion, a PE ratio of 19.51, a price-to-earnings-growth ratio of 1.37 and a beta of 1.20. The stock’s fifty day simple moving average is $35.01 and its 200-day simple moving average is $44.72. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.